Literature DB >> 629453

Effects of topical 1-epinephrine and dipivalyl epinephrine on intraocular pressure and pupil size in the normotensive and glaucomatous Beagle.

R M Gwin, K N Gelatt, G G Gum, R L Peiffer.   

Abstract

Dipivalyl epinephrine and l-epinephrine were evaluated in various concentrations in normotensive and glaucomatous Beagles. In higher concentrations, both drugs produced significant lowering of intraocular pressure. Mydriasis and some local irritation occurred. The hypotony after drug administration tended to be greater in glaucomatous than in normotensive Beagles. The glaucomatous Beagle may be a valuable biomedical model in the investigation of various pharmacologic substances.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 629453

Source DB:  PubMed          Journal:  Am J Vet Res        ISSN: 0002-9645            Impact factor:   1.156


  5 in total

1.  The effect of trabeculectomy on the aqueous humor flow of the unoperated fellow eye.

Authors:  M Diestelhorst; G Krieglstein
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1991       Impact factor: 3.117

2.  The consensual ophthalmotonic reaction.

Authors:  M V Gibbens
Journal:  Br J Ophthalmol       Date:  1988-10       Impact factor: 4.638

3.  Functional and structural changes in a canine model of hereditary primary angle-closure glaucoma.

Authors:  Sinisa D Grozdanic; Helga Kecova; Matthew M Harper; Wijitha Nilaweera; Markus H Kuehn; Randy H Kardon
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-08-06       Impact factor: 4.799

4.  Primary open angle glaucoma: inherited primary open angle glaucoma in the beagle.

Authors:  K N Gelatt; G G Gum; R M Gwin; N M Bromberg; R E Merideth; D A Samuelson
Journal:  Am J Pathol       Date:  1981-02       Impact factor: 4.307

5.  Intraocular Pressure-Lowering Efficacy of a Sustained-Release Bimatoprost Implant in Dog Eyes Pretreated with Selective Laser Trabeculoplasty.

Authors:  Corine Ghosn; Lakshmi Rajagopalan; Sveti Ugarte; Shruti Mistry; Werhner Orilla; Margot L Goodkin; Michael R Robinson; Michael Engles; Mohammed Dibas
Journal:  J Ocul Pharmacol Ther       Date:  2022-04-18       Impact factor: 2.850

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.